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Background/aim: This retrospective study evaluated the clinical presentation, underlying lung disease, surgical indications, technique,
treatment outcomes, and postoperative complications of pulmonary aspergilloma.
Materials and methods: We evaluated 77 patients who underwent pulmonary resection of an aspergilloma at Atatürk Chest Diseases
and Thoracic Surgery Research and Training Hospital between January 2000 and December 2013. The initial operations were 4
pneumonectomies, 24 lobectomies, 9 lobectomy plus myoplasties, 10 segmental resections, and 30 wedge resections. Six reoperations
were carried out to deal with postoperative complications: 1 myoplasty, 2 completion lobectomies plus myoplasties, 2 myoplasties with
rib resections, and 1 completion lobectomy.
Results: The subjects comprised 53 males (mean age: 44.26 (range: 10–73) years) and 24 females (mean age: 48.25 (range: 26–70)
years). The most common indication for surgery was hemoptysis in 52 patients (67.53%). The most common underlying lung disease
was tuberculosis in 37 patients (48.05%). Forty patients (51.94%) had a simple pulmonary aspergilloma and 37 (48.05%) had a complex
pulmonary aspergilloma. Major complications occurred in 18 patients (23.37%). The postoperative mortality rate was 3.89%, with 3
patients dying.
Conclusion: Surgical resection of pulmonary aspergilloma is the best way to prevent recurrent hemoptysis with low morbidity and
mortality.
Key words: Aspergilloma, surgery, complication

1. Introduction
Pulmonary aspergilloma is the most common human
disease caused by saprophytic species of the genus
Aspergillus (1,2). It involves the formation of a fungus ball
or mycetoma. Antifungal agents are usually ineffective
and a cure can be achieved only with surgical treatment
(1,3,4). Patients with an aspergilloma require surgical
treatment because there is a risk of sudden life-threatening
hemoptysis, and alternative medical treatments are
usually ineffective. However, the surgical indications
remain controversial because of the high incidence of
postoperative complications (1,5,6).
This retrospective study analyzed the clinical
presentation, underlying lung disease, surgical indications,
techniques, treatment outcomes, and postoperative
complications of pulmonary aspergilloma.
2. Materials and methods
We operated on 77 patients for pulmonary aspergilloma
between January 2000 and December 2013. The medical
* Correspondence: dr.k.aydogdu@hotmail.com

records were reviewed to determine the patients’ history,
clinical presentation, underlying lung disease, indications
for surgery, surgical procedures, and postoperative
complications. The subjects included 53 males (mean age:
44.26 (range: 10–73) years) and 24 females (mean age:
48.25 (range: 26–70) years).
The patients were diagnosed based on history and
radiological findings on a posteroanterior lung X-ray or
computed tomography. We classified the lesions as simple
pulmonary aspergilloma (SPA) if the lesion was welllocalized, with a thin-walled cavity smaller than 5 cm and
little or no surrounding atelectasis or consolidated areas.
Lesions were classified as complex pulmonary aspergilloma
(CPA) if they were well-localized, thin-walled cavities
larger than 5 cm or with thick walls, and surrounded by
parenchymal sequelae as disseminated consolidation and
atelectasis resulting from underlying lung disease, such
as bronchiectasis or tuberculosis in most cases (Figure 1)
(7–11).
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Figure 1. Computed tomography (CT) images of 2 cases of SPA and CPA.

The degree of hemoptysis was categorized by the
amount of blood lost in 24 h as major hemoptysis if the
volume lost exceeded 250 mL and minor hemoptysis if
the volume lost was less than 250 mL or the sputum was
stained with blood.
3. Results
Forty patients (51.94%) had SPA and 37 (48.05%) had
CPA. The most common underlying lung disease was
tuberculosis in 37 patients (48.05%), 19 with SPA and 18
with CPA. Bronchiectasis was the underlying lung disease
in 10 patients (12.98%), 7 with SPA and 3 with CPA. Six
patients had chronic obstructive lung disease (7.79%),
2 with SPA and 4 with CPA. One patient with CPA also
had a hydatid cyst (1.29%). Twenty-three patients had no
underlying lung disease (Table 1).
The most common presenting symptom and indication
for surgery was hemoptysis (67.53%; 52 patients, 43 with
minor hemoptysis and 9 with major hemoptysis). Of the
patients with major hemoptysis, 4 had SPA and 5 had CPA;
of those with minor hemoptysis, 33 had SPA and 10 had
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CPA. Another symptom was chronic cough in 17 patients
(22.07%; 17), 5 with SPA and 12 with CPA. Seven patients
presented with chest pain; 4 had SPA and 3 had CPA.
One patient with CPA presented with chronic abundant
sputum expectoration (Table 2).
The initial operations comprised 24 lobectomies,
4 pneumonectomies, 9 lobectomies plus myoplasties,
10 segmental resections, and 30 wedge resections.
Lobectomies were performed in 24 patients (31.16%),
16 with CPA and 8 with SPA. The 4 patients undergoing
pneumonectomies (5.19%) had CPA. Segmental resection
was performed in 10 patients (12.98%), 6 with SPA and
4 with CPA. Thirty patients (38.96%) required wedge
resection, 22 with SPA and 8 with CPA (Table 3).
Major complications occurred in 18 patients (23.37%)
and included repeated hemoptysis (n = 2), prolonged air
leak with or without empyema (n = 6), persistent pleural
space problems with or without empyema (n = 6), wound
infections (n = 3), and bronchopleural fistula (n = 1). The
postoperative mortality was 3.89% (n = 3) (Table 4). The
reoperations to deal with postoperative complications
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Table 1. Underlying lung diseases
Underlying diseases
Type

Tuberculosis

Bronchiectasis

Bullose emhysema

Cyst hidatid

SPA

19

7

2

-

CPA

18

3

4

1

Total

37

10

6

1

Table 2. Presenting symptoms and indications for surgery.
Symptoms
Type

Major hemoptysis

Minor hemoptysis

Cough

Chest pain

Abundant sputum

SPA

4

33

5

4

-

CPA

5

10

12

3

1

Total

9

43

17

7

1

Table 3. The initial operations performed.
Operation type
Type

Pneumonectomy

Lobectomy

Lobectomy + myoplasty

Segmentectomy

Wedge resection

SPA

-

8

1

6

22

CPA

4

16

8

4

8

Total

4

24

9

10

30

Table 4. The postoperative complications.
Complicatıons
Type

Prolonged air leak

Space

Broncopleural fistula

Wound infection

Hemoptysis

Exitus

SPA

5

5

-

1

-

-

CPA

1

1

1

2

2

3

Total

6

6

1

3

2

3

included 1 myoplasty, 1 completion lobectomy, 2
myoplasties with costal resections, and 2 lobectomies
plus myoplasties. No postoperative complications were
observed after the reoperations. Postoperative early
mortality occurred in 3 patients.
4. Discussion
Aspergillus is a genus of saprophytic fungi that occur widely
in nature. These species reproduce by forming conidia,
and airway contamination is usually via inhalation. A
pulmonary aspergilloma is the most common form of

human disease caused by Aspergillus and involves the
formation of a fungus ball or mycetoma (1,2,12–14). The
mass consists of viable or dead fungal elements, mucus,
blood, cell remnants, and inflammatory cells partially
occupying a cavity in communication with the airways or
in ectatic bronchi (1,3).
Pulmonary aspergillomas generally form in preexisting
pulmonary cavities caused by various diseases, such as
lung cancer, cystic fibrosis, abscesses, bullous emphysema,
cysts, hydatid cysts, and tuberculosis (1,2,7,15,16). Old
chronic tuberculosis cavities remain the most frequent
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underlying focus of disease, present in 13–89% of cases
(2). In our series, tuberculosis was the most common
underlying disease, present in 37 patients (Table 1). In
the literature some authors reported that there was not
any underlying lung disease identified in 12%–25% of
cases (7,8,11). In our series, underlying lung disease was
not identified in 23 patients (29%), higher than the rate
reported in the literature.
The clinical picture of aspergilloma ranges from
incidental radiological findings to life-threatening
hemoptysis, cough, dyspnea, and general weakness that
can be explained by an underlying lung disease rather
than aspergilloma (1,3). The most common symptom
is hemoptysis, as in our series (Table 2). In some series,
the incidence of hemoptysis in patients with aspergilloma
ranged from 50% to 83% (1,2,7,17–19). In our series,
52 (67.53%) patients had hemoptysis, 43 with minor
hemoptysis and 9 with major hemoptysis.
Some surgeons agree that minor hemoptysis can be
managed conservatively. After formation of the fungus
ball, antifungal agents are usually ineffective and the
natural dissolution of an aspergilloma with symptom
resolution is extremely rare, so life-threatening hemoptysis
is an important risk. Life-threatening hemoptysis is
not predicted by the size or complexity of the lesion,
forewarning minor hemoptysis, or the type of underlying
disease (2–4,20–23). Therefore, patients with a diagnosis
of aspergilloma should be treated surgically as soon as
possible to avoid major complications. Most reports
advocate surgery as the mainstay of treatment. Since
surgical resection has the benefits of preventing hemoptysis
and growth of the aspergilloma while preserving the lung
parenchyma and eradicating the pyogenic component,
greater life expectancy might result. Although a successful
lobectomy for pulmonary aspergilloma was first described
in 1948, surgical resection was once infrequent because
of the high incidence of complications and mortality.

Subsequently, many studies have shown that pulmonary
aspergilloma surgery has a low complication rate, and
surgical resection is now accepted as the treatment for
pulmonary aspergilloma (7,13,21,24,25).
Nevertheless, some authors still consider surgery
controversial because of the high incidence of postoperative
complications and mortality rates that range from 7% to
24.5% (1,6,19,26,27). Shirakusa et al. said that the greatest
possible amount of healthy parenchyma must be spared
because of the saprophytic character of the organism (17).
Open thoracotomy and anatomical resection have become
widely accepted as the main treatments for pulmonary
aspergilloma in patients who are suitable candidates for
surgery (12).
In our study, the operations comprised anatomical
resections in 47 patients: lobectomy, n = 24, 31.16%;
pneumonectomy, n = 4, 5.19%; lobectomy plus myoplasty, n
= 9, 11.68%; segmental resection, n = 10, 12.98%; and wedge
resection, n = 30, 38.96%. Of the 24 patients undergoing
lobectomy, the underlying disease was tuberculosis in 14.
In this group, only 5 patients had complications (20%)
(1 prolonged air leak and empyema, 2 thoracic spaces, 1
major hemoptysis, and 1 wound infection) and none of
them required reoperation. In 3 of these 5 patients with
complications, the underlying disease was tuberculosis.
The 2 patients with space complications did not require
reoperations and were followed as a sterile space (Figure 2).
No hemoptysis episodes that required reoperation occurred
in any of the patients who underwent lobectomy. One patient
with bullous emphysema had major hemoptysis resulting
from a bronchopleural fistula and was treated medically. If
the underlying disease is tuberculosis, we should take care
to prevent space and prolonged air leak problems. Any
judgment as to whether to reduce the thoracic cavity should
be reserved for space problems. During a lobectomy, we
should take precautions to prevent parenchymal air leaks,
especially with underlying tuberculosis.

Figure 2. Sterile space complications that did not require reoperation.

434

AYDOĞDU et al. / Turk J Med Sci
Nine patients underwent a lobectomy plus myoplasty,
all of whom had tuberculosis (Figure 3). In this group, 1
patient had a prolonged air leak and empyema and 1 had
a wound infection (22%) that did not require reoperation.
Although the diagnosis was tuberculosis, the absence
of space problems in all of the patients who underwent
lobectomy and myoplasty is an important result. This also
shows that we need to perform a myoplasty when faced
with possible expansion problems in patients who undergo
a lobectomy. When we consider the reoperation group,
5 myoplasties were performed in 6 patients. Therefore,
we should consider performing a myoplasty to obviate
the need for reoperation when postoperative expansion
problems are expected to occur.
Ten patients had anatomical segmental resections, of
whom 5 had tuberculosis. There were 2 complications:
1 patient had space complications (20%) and required
reoperation (lobectomy plus myoplasty), and 1 had a
wound infection. In addition, in this group, the problem
of space resulting from expansion failure required
reoperation. In these 43 patients, anatomical lobectomy
and segmental resections were performed; only 9 patients
had complications (20%), only 1 of whom required
reoperation (2%). Thirty patients had wedge resections,
and tuberculosis was the underlying disease in 9 of
them. Nine of the 30 patients undergoing applied wedge
resections had complications (30%) and 5 required
reoperation (16%). Therefore, we think that compared
with anatomic resections, wedge resections should never
be preferred in terms of postoperative complications and
the need for reoperation.
Five patients were operated on for destroyed lungs,
of whom 4 had tuberculosis. The operations for these
destroyed lungs were 3 left pneumonectomies, 1 right
pneumonectomy, and 1 left upper lobectomy. In this
group, 3 patients had complications and 3 had tuberculosis
(75%): 1 patient died from empyema, 1 patient had

empyema and was treated with antibiotics and pleural
lavage, and 1 patient had a wound infection. If the cause
of a destroyed lung is tuberculosis, we must be careful to
avoid complications.
In terms of complication types and the need for
reoperation, 18 complications occurred (23.37%). Fifteen
of these were related to parenchymal failure and 3 to wound
infection (treated with antibiotics and then resutured).
The 15 complications related to parenchymal failure
included repeated hemoptysis (n = 2), prolonged air leak
with empyema (n = 6), persistent pleural space problems
with or without empyema (n = 6), and bronchopleural
fistula (n = 1). Reoperation was needed in the patients
with repeated hemoptysis and space complications.
The reoperations included 1 myoplasty, 1 completion
lobectomy, 2 myoplasties with costal resections, and 2
lobectomies plus myoplasties to deal with postoperative
complications. No postoperative complications were
observed after the reoperations. The other complications
were corrected with medical treatments or chronic tube
drainage.
Repeated hemoptysis was defined as a patient who
was operated on for hemoptysis and then developed
hemoptysis postoperatively. There were 2 patients in
this group; 1 had SPA and 1 had CPA. In this group, the
initial operations were wedge resections, but recurrences
occurred (Figure 4) and both patients required
reoperations; the post-reoperation pathology was also an
aspergilloma. Prolonged air leaks were defined as those
lasting more than 15 days; empyema occurred in some of
these patients. There were 6 patients in this group, 5 with
SPA and 1 with CPA, of whom 5 had tuberculosis. In 4 of
the 5 patients with SPA the initial operations were wedge
resections, and the other was lobectomy. In this group the
patient with CPA had lobectomy plus myoplasty. In this
group, none of the patients required reoperation; they
were treated with antibiotics and pleural space lavage.

Figure 3. Preoperative CT image and postoperative chest X-ray of a patient who underwent a lobectomy
plus myoplasty.
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Figure 4. After an initial wedge resection, recurrence was observed at the same location.

A space problem occurs when the thoracic cavity is not
completely filled with lung parenchyma, and empyema was
seen in some of these patients. In this group, all of them
had SPA and the first operation was a wedge resection in
3 patients, segmental resection in 1, and lobectomy in 2.
The patients in this group who underwent initial wedge
or segmental resections required reoperations. A wedge
resection was the most common operation in patients
subsequently developing both prolonged air leaks and
space complications. In 9 of the 12 patients with prolonged
air leaks or space complications, tuberculosis was the
underlying disease. Tuberculosis was also the underlying
disease in 2 of the 3 patients with wound infections.
Three patients (3.8%) died: 1 each from major
hemoptysis, postoperative pneumonia, and empyema. The
last 2 underwent a lobectomy plus myoplasty. The patient
who died from hemoptysis had bilateral cavitary lesions
and underwent a right upper lobectomy and myoplasty.
The hemoptysis was major and occurred from the left side.

The patient who died from postoperative pneumonia had
a left upper lobectomy and myoplasty. The last patient had
a left pneumonectomy for a destroyed lung and died 1
month after the operation from empyema.
From this experience, we conclude that surgical
resection for aspergilloma offers potential benefits with
acceptably low morbidity and mortality rates in accordance
with the literature. However, the surgical resections must
consist of anatomical resections, such as lobectomy and
segmentectomy. If the underlying disease is tuberculosis,
space problems and prolonged air leak must be considered.
Therefore, during the preoperative evaluation if
parenchyma expansion failure and air leakage is expected,
we recommend that the surgeon perform a myoplasty. In
the treatment of aspergilloma, wedge resections should
always be avoided because the postoperative complication
rate is high and reoperation is required in all cases.
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